Davis Polk Advises Roche In $230M Deal To Buy Anadys
Swiss drug giant Roche Holding AG said Monday it had agreed to buy Anadys Pharmaceuticals Inc. for roughly $230 million to boost its offerings for treating hepatitis C....To view the full article, register now.
Already a subscriber? Click here to view full article